257.92
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Resmed Inc Aktie (RMD) Neueste Nachrichten
What analysts say about ResMed Inc. stockDynamic growth stocks - Jammu Links News
Published on: 2025-07-19 18:08:41 - Jammu Links News
What makes ResMed Inc. stock attractive to long term investorsTrend Based Entry Alerts - beatles.ru
Is ResMed Inc. a good long term investmentExplosive portfolio gains - Jammu Links News
ResMed Inc. Stock Analysis and ForecastAccelerated wealth building - Jammu Links News
This ResMed Insider Reduced Their Stake By 72% - simplywall.st
This Pick Withstood the GLP-1 Challenge. Stick With the Stock. - Barron's
Analyst Expectations For ResMed's Future - Nasdaq
ResMed (RMD) Price Target Increased to $270 by Mizuho Analyst | - GuruFocus
Brokers Set Expectations for ResMed's Q1 Earnings (NYSE:RMD) - MarketBeat
RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 - MarketScreener
ResMed's Trading Volume Surges 78.7% to 2.35 Billion, Stock Price Drops 0.11% Placing 406th in Market Rankings - AInvest
ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - 富途牛牛
ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan - TipRanks
Resmed CEO Farrell sells $2.06 million in stock By Investing.com - Investing.com Canada
Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing - MarketScreener
ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144 - TipRanks
With 75% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - simplywall.st
ResMed CFO Reports Changes in Stock Ownership - TipRanks
ResMed to Release Q4 2025 Financial Results on July 31, 2025, via Webcast - AInvest
ResMed Executives Sell Shares Under Pre-arranged Trading Plans - TradingView
ResMed Director Announces Further Share Sale - TipRanks
ResMed Chief Legal Officer Sells Shares - MarketScreener
Resmed Inc Officer Files Notice for Stock Sale Under Rule 144 - TipRanks
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 | RMD Stock News - GuruFocus
Resmed Announces Fourth Quarter Fiscal Year 2025 Financial Results Release and Webcast Details - Nasdaq
ResMed (NYSE:RMD) Shows Growth in ROCE and Business Efficiency NYSE Composite - Kalkine Media
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 - Morningstar
Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed - Yahoo Finance
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy - Yahoo Finance
Is the ResMed share price still cheap? What the numbers say - The Motley Fool Australia
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Bi Level Automatic Ventilator Market Is Booming Worldwide 2025-2032 | ResMed Inc., Philips Healthcare, Medtronic Plc - openPR.com
ResMed Stock: Is RMD Outperforming the Healthcare Sector? - MSN
ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside - DirectorsTalk Interviews
ResMed Stock: Is RMD Outperforming The Healthcare Sector? - Barchart.com
Resmed CEO Michael Farrell sells shares worth $2.01 million By Investing.com - Investing.com South Africa
ResMed: A Mixed Bag for Investors Amid Rising Competition - The Globe and Mail
Resmed CEO Michael Farrell sells shares worth $2.01 million - Investing.com
ResMed CEO Sells Shares Worth $2 Million - MarketScreener
ResMed Inc Reports Change in Beneficial Ownership - TipRanks
ResMed: A Sleeping Giant Hiding In Plain Sight (NYSE:RMD) - Seeking Alpha
Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? - MSN
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed director Peter Farrell sells $494,640 in stock By Investing.com - Investing.com Nigeria
ResMed director Peter Farrell sells $494,640 in stock - Investing.com Australia
ResMed Inc Director Proposes Sale of Common Shares - TipRanks
Successful Exits - University College Dublin
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed CFO Sells Shares - marketscreener.com
Resmed Inc Reports Decrease in CDI Issuance for May 2025 - TipRanks
ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):